abs368.txt	introduction		the	procoagulant	activity	of	extracellular	vesicles	(ev)	exposingtissue	factor	(tf)	is	a	promising	biomarker	for	venous	thromboembolism	(vte)	incancer	patients		we	evaluated	an	in-house	ev-tf	activity	assay	(the	fibringeneration	test)	for	the	prediction	of	cancer-associated	vte		we	also	comparedthe	results	with	the	fibrin	generation	tests	to	an	ev-tf-dependent	factor	xageneration	assay	in	samples	from	pancreatic	cancer	patients	materials	and	methods		data	collected	in	a	multinational		prospective	cohortstudy	were	used		patients	with	various	types	of	advanced	cancer	were	enrolled	ifchemotherapy	was	scheduled	or	started	in	the	previous	3	months		patients	werefollowed	for	6	months	for	the	occurrence	of	vte		the	fibrin	generation	test	wasperformed	at	baseline	to	measure	ev-tf	procoagulant	activity	results		the	fibrin	generation	test	was	performed	in	648	patients	with	advancedcancer		the	mean	age	was	62	years		58%	had	distant	metastasis		forty	patients(6	1%)	developed	vte		overall		a	high	fibrin	generation	test	result	wasassociated	with	a	two-fold	increased	risk	for	vte	(hr	2	0		95%-ci		1	1-3	6)		theassociation	was	stronger	in	patients	with	pancreatic	cancer	(hr	4	1		95%-ci	0	91-19)	than	in	those	with	other	tumor	types	(hr	1	5		95%-ci		0	72-3	1)	correlation	between	the	fgt	and	the	tf-dependent	factor	xa	generation	assay	inpatients	with	pancreatic	cancer	was	poor	(spearman's	r	=	0	35)	conclusion		this	study	shows	that	a	high	ev-tf	procoagulant	activity	as	measuredby	the	fibrin	generation	test	is	associated	with	an	increased	risk	of	vte	incancer	patients		in	particular	in	those	with	pancreatic	cancer		future	studiesshould	aim	to	further	improve	the	feasibility	and	accuracy	of	ev-tf	activityassays	
